BDBM155906 US10118915, Compound 142::US9682966, 130::US9682966, 131::US9682966, 141::US9682966, 142

SMILES CC(=N)c1cc(Br)cnc1N1CC[C@@H](NC2CCCCC2)[C@H](O)C1

InChI Key InChIKey=DSTNTGACLBPWOV-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 155906   

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 22nMT: 2°CAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements. The carboxy terminus of the OPRK1 receptor has a 7 amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 22nMAssay Description:Well-known assay for kappa opioid receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 30nMT: 2°CAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements. The carboxy terminus of the OPRK1 receptor has a 7 amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 30nMAssay Description:Well-known assay for kappa opioid receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 107nMT: 2°CAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements. The carboxy terminus of the OPRK1 receptor has a 7 amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 107nMAssay Description:Well-known assay for kappa opioid receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 125nMAssay Description:Well-known assay for kappa opioid receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
Go to US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM155906(US9682966, 131 | US9682966, 142 | US9682966, 141 |...)
Affinity DataIC50: 125nMT: 2°CAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements. The carboxy terminus of the OPRK1 receptor has a 7 amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
Go to US Patent